Tumor immunoediting by NKp46

Journal of Immunology

Volumn 184, Issue 10, 2010, Pages 5637-5644

  Elboim, Moran ^a   Gazit, Roi ^b   Gur, Chamutal ^a   Ghadially, Hormas ^a   Betser Cohen, Gili ^a   Mandelboim, Ofer ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b HARVARD STEM CELL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLCHOLANTHRENE; GAMMA INTERFERON; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NATURAL KILLER CELL RECEPTOR; LIGAND; LY ANTIGEN; NCR1 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; CYTOKINE RELEASE; FIBROSARCOMA; IMMUNOGENICITY; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; TUMOR IMMUNOLOGY; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL STRAIN COS1; CERCOPITHECUS; CHEMICALLY INDUCED DISORDER; COCULTURE; GENETICS; IMMUNOLOGY; IMMUNOSURVEILLANCE; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; SECRETION; TRANSGENIC MOUSE; TUMOR CELL LINE; TUMOR ESCAPE;

ANIMALS; ANTIGENS, LY; CELL LINE, TUMOR; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; COCULTURE TECHNIQUES; COS CELLS; FIBROSARCOMA; IMMUNOLOGIC SURVEILLANCE; INTERFERON-GAMMA; KILLER CELLS, NATURAL; LIGANDS; METHYLCHOLANTHRENE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; TUMOR ESCAPE;

EID: 77954734104     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0901644     Document Type: Article

References (37)

1. Arnon, T. I., G. Markel, and O. Mandelboim. 2006. Tumor and viral recognition by natural killer cells receptors. Semin. Cancer Biol. 16: 348-358.
2. Lodoen, M. B., and L. L. Lanier. 2006. Natural killer cells as an initial defense against pathogens. Curr. Opin. Immunol. 18: 391-398.
3. Newman, K. C., and E. M. Riley. 2007. Whatever turns you on: accessory-cell-dependent activation of NK cells by pathogens. Nat. Rev. Immunol. 7: 279-291.
4. Achdout, H., I. Manaster, and O. Mandelboim. 2008. Influenza virus infection augments NK cell inhibition through reorganization of major histocompatibility complex class I proteins. J. Virol. 82: 8030-8037.
5. Moretta, A., C. Bottino, M. Vitale, D. Pende, C. Cantoni, M. C. Mingari, R. Biassoni, and L. Moretta. 2001. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu. Rev. Immunol. 19: 197-223.
6. Welte, S., S. Kuttruff, I. Waldhauer, and A. Steinle. 2006. Mutual activation of natural killer cells and monocytes mediated by NKp80-AICL interaction. Nat. Immunol. 7: 1334-1342.
7. Gazit, R., R. Gruda, M. Elboim, T. I. Arnon, G. Katz, H. Achdout, J. Hanna, U. Qimron, G. Landau, E. Greenbaum, et al. 2006. Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1. Nat. Immunol. 7: 517-523.
8. Bauer, S., V. Groh, J. Wu, A. Steinle, J. H. Phillips, L. L. Lanier, and T. Spies. 1999. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285: 727-729. (Pubitemid 129505074)
9. Brandt, C. S., M. Baratin, E. C. Yi, J. Kennedy, Z. Gao, B. Fox, B. Haldeman, C. D. Ostrander, T. Kaifu, C. Chabannon, et al. 2009. The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans. J. Exp. Med. 206: 1495-1503.
10. Ljunggren, H. G. 2008. Cancer immunosurveillance: NKG2D breaks cover. Immunity 28: 492-494.
11. Pogge von Strandmann, E., V. R. Simhadri, B. von Tresckow, S. Sasse, K. S. Reiners, H. P. Hansen, A. Rothe, B. Böll, V. L. Simhadri, P. Borchmann, et al. 2007. Human leukocyte antigen-B-associated transcript 3 is released from tumor cells and engages the NKp30 receptor on natural killer cells. Immunity 27: 965-974.
12. Arnon, T. I., M. Lev, G. Katz, Y. Chernobrov, A. Porgador, and O. Mandelboim. 2001. Recognition of viral hemagglutinins by NKp44 but not by NKp30. Eur. J. Immunol. 31: 2680-2689.
13. Mandelboim, O., N. Lieberman, M. Lev, L. Paul, T. I. Arnon, Y. Bushkin, D. M. Davis, J. L. Strominger, J. W. Yewdell, and A. Porgador. 2001. Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 409: 1055-1060.
14. Arnon, T. I., H. Achdout, O. Levi, G. Markel, N. Saleh, G. Katz, R. Gazit, T. Gonen-Gross, J. Hanna, E. Nahari, et al. 2005. Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus. Nat. Immunol. 6: 515-523.
15. Jonjić, S., M. Babić, B. Polić, and A. Krmpotić. 2008. Immune evasion of natural killer cells by viruses. Curr. Opin. Immunol. 20: 30-38.
16. Lanier, L. L. 2008. Evolutionary struggles between NK cells and viruses. Nat. Rev. Immunol. 8: 259-268.
17. Halfteck, G. G.,M. Elboim, C. Gur, H.Achdout, H. Ghadially, and O. Mandelboim. 2009. Enhanced in vivo growth of lymphoma tumors in the absence of the NK-activating receptor NKp46/NCR1. J. Immunol. 182: 2221-2230.
18. Lakshmikanth, T., S. Burke, T. H. Ali, S. Kimpfler, F. Ursini, L. Ruggeri, M. Capanni, V. Umansky, A. Paschen, A. Sucker, et al. 2009. NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo. J. Clin. Invest. 119: 1251-1263.
19. Guerra, N., Y. X. Tan, N. T. Joncker, A. Choy, F. Gallardo, N. Xiong, S. Knoblaugh, D. Cado, N. M. Greenberg, N. R. Greenberg, and D. H. Raulet. 2008. NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy. [Published erratum appears in 2008 Immunity 28: 723.] Immunity 28: 571-580.
20. Koebel, C. M., W. Vermi, J. B. Swann, N. Zerafa, S. J. Rodig, L. J. Old, M. J. Smyth, and R. D. Schreiber. 2007. Adaptive immunity maintains occult cancer in an equilibrium state. Nature 450: 903-907.
21. Iguchi-Manaka, A., H. Kai, Y. Yamashita, K. Shibata, S. Tahara-Hanaoka, S. Honda, T. Yasui, H. Kikutani, K. Shibuya, and A. Shibuya. 2008. Accelerated tumor growth inmice deficient in DNAM-1 receptor. J. Exp. Med. 205: 2959-2964.
22. Smyth, M. J., J. Swann, E. Cretney, N. Zerafa, W. M. Yokoyama, and Y. Hayakawa. 2005. NKG2D function protects the host from tumor initiation. J. Exp. Med. 202: 583-588.
23. Mandelboim, O., H. T. Reyburn, M. Valés-Gómez, L. Pazmany, M. Colonna, G. Borsellino, and J. L. Strominger. 1996. Protection from lysis by natural killer cells of group 1 and 2 specificity is mediated by residue 80 in human histocompatibility leukocyte antigen C alleles and also occurs with empty major histocompatibility complex molecules. J. Exp. Med. 184: 913-922.
24. Beuneu, H., J. Deguine, B. Breart, O. Mandelboim, J. P. Di Santo, and P. Bousso. 2009. Dynamic behavior of NK cells during activation in lymph nodes. Blood 114: 3227-3234.
25. + cells that provide innate mucosal immune defense. Immunity 29: 958-970.
26. Sozmen, M., R. Tunca, and S. Dag Erginsoy. 2008. Cyclin A expression is associated with apoptosis and mitosis in murine 3-methylcholanthrene-induced fibrosarcomas. Exp. Toxicol. Pathol. 61: 41-49.
27. Swann, J. B., M. D. Vesely, A. Silva, J. Sharkey, S. Akira, R. D. Schreiber, and M. J. Smyth. 2008. Demonstration of inflammation-induced cancer and cancer immunoediting during primary tumorigenesis. Proc. Natl. Acad. Sci. USA 105: 652-656.
28. Di Santo, J. P. 2008. Natural killer cells: diversity in search of a niche. Nat. Immunol. 9: 473-475.
29. Cooper, M. A., J. M. Elliott, P. A. Keyel, L. Yang, J. A. Carrero, and W. M. Yokoyama. 2009. Cytokine-induced memory-like natural killer cells. Proc. Natl. Acad. Sci. USA 106: 1915-1919.
30. O'Leary, J. G., M. Goodarzi, D. L. Drayton, and U. H. von Andrian. 2006. T cell- and B cell-independent adaptive immunity mediated by natural killer cells. Nat. Immunol. 7: 507-516.
31. Sun, J. C., J. N. Beilke, and L. L. Lanier. 2009. Adaptive immune features of natural killer cells. Nature 457: 557-561.
32. Bryceson, Y. T., and E. O. Long. 2008. Line of attack: NK cell specificity and integration of signals. Curr. Opin. Immunol. 20: 344-352.
33. Blankenstein, T., and Z. Qin. 2003. The role of IFN-g in tumor transplantation immunity and inhibition of chemical carcinogenesis. Curr. Opin. Immunol. 15: 148-154.
34. Bryceson, Y. T., M. E. March, H. G. Ljunggren, and E. O. Long. 2006. Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. Blood 107: 159-166.
35. Draghi, M., A. Pashine, B. Sanjanwala, K. Gendzekhadze, C. Cantoni, D. Cosman, A. Moretta, N. M. Valiante, and P. Parham. 2007. NKp46 and NKG2D recognition of infected dendritic cells is necessary for NK cell activation in the human response to influenza infection. J. Immunol. 178: 2688-2698.
36. Achdout, H., T. Meningher, S. Hirsh, A. Glasner, Y. Bar-On, C. Gur, A. Porgador, M. Mendelson, M. Mandelboim, and O. Mandelboim. 2010. Killing of avian and swine influenza by natural killer cells. J. Virol. 84: 3993-4001.
37. Gur, C., A. Porgador, M. Elboim, R. Gazit, S. Mizrahi, N. Stern-Ginossar, H. Achdout, H. Ghadially,Y. Dor, T. Nir, et al. 2010. The activating receptor NKp46 is essential for the development of type 1 diabetes. Nat. Immunol. 11: 121-128.